Optimize IAS
  • Home
  • About Us
  • Free Initiatives
    • Daily Practice Sheets
    • Daily Prelims Notes
    • Prelims Power Play
    • Friday Factly
    • Sunday Essay Sadhna
    • Mains Master Notes
  • My Mentorship
    • Prelims 2023
      • Laqshya 2023
      • Laqshya 2023 OPTIMA
    • Personalized Guidance 2023
      • ARJUNA Prime 2023
      • ARJUNA 2023
    • Mains 2022
      • Mains Optima (Current)
      • Mains Mentorship Program (Static)
    • Know More
  • Resources
    • DPS Compilation
    • DPN Compilation
    • Toppers Notes
      • PSIR Notes
      • General Studies Notes
    • UPSC Mains Previous Year Papers
  • Login
  • Home
  • About Us
  • Free Initiatives
    • Daily Practice Sheets
    • Daily Prelims Notes
    • Prelims Power Play
    • Friday Factly
    • Sunday Essay Sadhna
    • Mains Master Notes
  • My Mentorship
    • Prelims 2023
      • Laqshya 2023
      • Laqshya 2023 OPTIMA
    • Personalized Guidance 2023
      • ARJUNA Prime 2023
      • ARJUNA 2023
    • Mains 2022
      • Mains Optima (Current)
      • Mains Mentorship Program (Static)
    • Know More
  • Resources
    • DPS Compilation
    • DPN Compilation
    • Toppers Notes
      • PSIR Notes
      • General Studies Notes
    • UPSC Mains Previous Year Papers
  • Login

Bharat Bio consortium gets $19 m to develop ‘variant-proof’ vaccine

  • May 11, 2022
  • Posted by: admin1
  • Category: DPN Topics
No Comments
Print Friendly, PDF & Email

 

 

Bharat Bio consortium gets $19 m to develop ‘variant-proof’ vaccine

Subject :Science and Technology

Section: Biotech

Context: An adjuvant subunit vaccine, designed to provide broad protection against all known SARS-CoV-2 variants

Concept: The Coalition for Epidemic Preparedness Innovations (CEPI) was launched at Davos in 2017 as the result of a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics.

It is an innovative global partnership between public, private, philanthropic, and civil society organizations working to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines for affected populations during outbreaks.

An adjuvanted subunit: Subunit vaccines are well-established as a reliable and safe platform effective against a variety of infectious diseases such as hepatitis B, diphtheria, pertussis, shingles and human papillomavirus.

What is an adjuvant and why is it added to a vaccine?

An adjuvant is an ingredient used in some vaccines that helps create a stronger immune response in people receiving the vaccine. In other words, adjuvants help vaccines work better. Some vaccines that are made from weakened or killed germs contain naturally occurring adjuvants and help the body produce a strong protective immune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. Adjuvants help the body to produce an immune response strong enough to protect the person from the disease he or she is being vaccinated against. Adjuvanted vaccines can cause more local reactions (such as redness, swelling, and pain at the injection site) and more systemic reactions (such as fever, chills and body aches) than non-adjuvanted vaccines.

Adjuvants have been used safely in vaccines for decades.

Aluminum salts, such as aluminum hydroxide, aluminum phosphate, and aluminum potassium sulfate have been used safely in vaccines for more than 70 years. Aluminum salts were initially used in the 1930s, 1940s, and 1950s with diphtheria and tetanus vaccines after it was found they strengthened the body’s immune response to these vaccines.

Newer adjuvants have been developed to target specific components of the body’s immune response, so that protection against disease is stronger and lasts longer.

Several different adjuvants are used

Several different adjuvants are used in U.S. vaccines.
AdjuvantCompositionVaccines
AluminumOne or more of the following: amorphous aluminum hydroxyphosphate sulfate (AAHS), aluminum hydroxide, aluminum phosphate,
potassium aluminum sulfate (Alum)
Anthrax, DT, DTaP (Daptacel), DTaP (Infanrix), DTaP-IPV (Kinrix), DTaP-IPV (Quadracel), DTaP-HepB-IPV (Pediarix), DTaP –IPV/Hib (Pentacel), Hep A (Havrix), Hep A (Vaqta), Hep B (Engerix-B), Hep B (Recombivax), HepA/Hep B (Twinrix), HIB (PedvaxHIB), HPV (Gardasil 9), Japanese encephalitis (Ixiaro), MenB (Bexsero, Trumenba), Pneumococcal (Prevnar 13), Td (Tenivac), Td (Mass Biologics), Tdap (Adacel), Tdap (Boostrix)
AS04Monophosphoryl lipid A (MPL) + aluminum saltCervarix
MF59Oil in water emulsion composed of squaleneFluad
AS01BMonophosphoryl lipid A (MPL) and QS-21, a natural compound extracted from the Chilean soapbark tree, combined in a liposomal formulationShingrix
CpG 1018Cytosine phosphoguanine (CpG), a synthetic form of DNA that mimics bacterial and viral genetic materialHeplisav-B
No adjuvantActHIB, chickenpox, live zoster (Zostavax), measles, mumps & rubella (MMR), meningococcal (Menactra, Menveo), rotavirus, seasonal influenza (except Fluad), single antigen polio (IPOL), yellow fever

Access to vaccines

Under the terms of the funding agreement, the consortium partners have agreed to achieve equitable access to the output of this project.

As repeated waves of Covid infection remind us, we will be living alongside the virus for many years to come. The threat of a new variant emerging that might evade the protection of our current vaccines is real.

Bharat Bio consortium gets $19 m to develop ‘variant-proof’ vaccine Science and tech
Print Friendly, PDF & Email
Loading

Recent Posts

  • Daily Prelims Notes 29 June 2022 June 29, 2022
  • Power of Speaker June 29, 2022
  • Pune-based Gennova Biopharmaceuticals mRNA vaccine June 29, 2022
  • Scotland eyes independence vote June 29, 2022
  • US-led Partners in the Blue Pacific June 29, 2022
  • Nadaprabhu Kempegowda June 29, 2022
  • TDS on crypto June 29, 2022
  • T-Hub 2.0 June 29, 2022
  • GST-Concepts June 29, 2022
  • PM Modi’s gift to G7 leaders June 29, 2022

About

If IAS is your destination, begin your journey with Optimize IAS.

Hi There, I am Santosh I have the unique distinction of clearing all 6 UPSC CSE Prelims with huge margins.

I mastered the art of clearing UPSC CSE Prelims and in the process devised an unbeatable strategy to ace Prelims which many students struggle to do.

Free Initiatives

  • Daily Practice Sheets
  • Daily Prelims Notes
  • Friday Factly
  • Prelims Power Play
  • Sunday Essay Sadhna

My Proven Strategy

  • Interview Strategy
  • Mains Strategy
  • Motivational
  • Prelims Strategy

Contact us

moc.saiezimitpo@tcatnoc

For More Details

Work with Us

Connect With Me

Santosh Pandey Quora Santosh Sir Telegram Santosh Sir Youtube Optimize IAS Instagram

Course Portal
Search